Navigation Links
ImmunoVaccine Technologies Partners with FIT Biotech to advance a therapeutic HIV vaccine
Date:5/26/2009

HALIFAX, NS, May 26 /PRNewswire/ - ImmunoVaccine Technologies Inc. (IVT), a Canadian vaccine development company, announced a research partnership with FIT Biotech, a Finland-based, clinical stage company that develops DNA vaccines. This research will formulate FIT Biotech's GTU(R) MultiHIV DNA plasmid with IVT's DepoVax(TM) vaccine delivery system to advance a therapeutic HIV vaccine.

"DepoVax(TM) will act as a vector to deliver FIT Biotech's GTU(R) MultiHIV DNA vaccine and our goal is to develop a more sophisticated and efficient HIV vaccine candidate," commented Dr. Marc Mansour, Vice President R&D at IVT.

The development of an HIV vaccine is complicated by the ability of the virus to mutate rapidly. FIT Biotech has addressed this challenge by designing a synthetic DNA plasmid, known as GTU(R) MultiHIV that covers the antigenic variability within HIV strains. GTU(R) MultiHIV and is comprised of the multi-epitope/multivalent HIV antigens. As FIT Biotech's lead vaccine candidate, GTU(R) MultiHIV has the potential to trigger an immune response that slows the progression of HIV in infected individuals.

IVT's pre-clinical research demonstrates that DepoVax(TM) effectively delivers DNA plasmids into draining lymph nodes with as little as one dose. The DepoVax(TM) platform uses liposomes to encapsulate a target antigen, like GTU(R) MultiHIV, and adjuvant. DepoVax(TM) also relies on a hydrophobic carrier to create a depot effect that significantly enhances vaccine induced cell-mediated and humoral immunity.

This pre-clinical research partnership will combine the complementary technologies of DepoVax(TM) and GTU(R) MultiHIV. Both IVT and FIT Biotech will examine the novel vaccine's capabilities of inducing cell-mediated and humoral immunity against HIV virus.

"By testing DepoVax(TM) in combination with GTU(R) MultiHIV plasmid, we are working towards developing a superior vaccine candidate for therapeutic use against HIV a
'/>"/>

SOURCE ImmunoVaccine Technologies Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. ImmunoVaccine Technologies Inc. Nears Phase I Clinical Trials with Completion of Scientific Advisory Board
2. ImmunoVaccine Technologies appoints the Honourable Michael Kirby as Chair
3. ImmunoVaccine Technologies Patents DepoVax(TM) Vaccine Platform
4. ImmunoVaccine Technologies Congratulates Dr. Ramila Philip as One of PAs Best 50 Women in Business
5. ImmunoVaccine Technologies Broadens Its Patent Protection to Japan
6. ImmunoVaccine Technologies Presents at OneMed Place Finance Forum
7. ImmunoVaccine Technologies Signs Agreement with National Institutes of Health to Explore Vaccines for HIV and Malaria
8. ImmunoVaccine Technologies Collaborates with Defence Research & Development Canada to Strengthen Canadas Ability to Deal with Biological Threats
9. ImmunoVaccine Technologies Collaborates with NRC Institute for Biodiagnostics Atlantic to measure effectiveness of DepoVax(TM) with novel MRI Imagin
10. ImmunoVaccine Technologies Collaborates with NRC Institute for Biodiagnostics Atlantic to measure effectiveness of DepoVax(TM) with novel MRI Imaging
11. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... 17, 2013 New interactive ... innovative thought leaders of the medical device industry ... conference and expo, from June 18-20 in ... http://photos.prnewswire.com/prnh/20130517/613829 ) , These ... industry professionals practical presentations and implementable solutions on ...
(Date:5/17/2013)... BEIJING , May 17, 2013  Yongye International, ... "Company"), a leading developer, manufacturer, and distributor of crop ... China , today announced that, on May 16, ... board of directors (the "Board of Directors") was provided ... ( Hong Kong ) Limited ("Abax") to ...
(Date:5/17/2013)... -- Insero Health, Inc., a company developing natural compounds to ... disorders, is today reporting top-line results from a Phase ... with drug-resistant epilepsy.  The data are being presented at ... by Dr. Steven Schachter , Harvard ... Board.  In this study, INS001 appeared safe and well ...
(Date:5/17/2013)... 2013 The paradigm of ‘one drug, ... that can help predict the adverse and therapeutic effects ... Head of Computational Biology at the Genomics Laboratory, Covance, ... ensure high-quality genomics when used as part of the ... complex data sets to identify key clinical targets even ...
Breaking Biology Technology:MedTech Innovate Seminars: New Interactive Learning Forums at 2013 MD&M East 2Yongye International Provides Update on Status of Proposed Go Private Offer 2Yongye International Provides Update on Status of Proposed Go Private Offer 3Yongye International Provides Update on Status of Proposed Go Private Offer 4Insero Health Reports Positive Data on Phase I Trial of Novel Therapy for Drug-resistant Epilepsy 2
... DIEGO, May 6 SpectraScience, Inc. (OTC ... device company, today announced that The Wall ... with Chief Executive Officer Jim Hitchin. The ... the company,s website at http://www.spectrascience.com/tinymce/jscripts/tiny_mce/plugins/ajaxfilemanager/uploaded/Wall%20Street%20Transcript.pdf ...
... Website on Cardiovascular Disease for Worldwide Learning and ... common heart condition or a rare complication, another ... why the Society for Cardiovascular Angiography and Interventions ... IC Sciences Company, today unveiled a new educational ...
... SOUTH SAN FRANCISCO, Calif., May 6 iZumi ... industrialization of induced pluripotent stem cell (iPS) technology ... cellular reprogramming and directed differentiation of patient cells, ... as chief technology officer (CTO) and Dushyant Pathak, ...
Cached Biology Technology:SpectraScience CEO Jim Hitchin Featured in Interview With The Wall Street Transcript 2SpectraScience CEO Jim Hitchin Featured in Interview With The Wall Street Transcript 3New Website Connects Physicians to Solve Challenging Cases and Share Experiences 2New Website Connects Physicians to Solve Challenging Cases and Share Experiences 3New Website Connects Physicians to Solve Challenging Cases and Share Experiences 4iZumi Bio Appoints Dr. Berta Strulovici as Chief Technology Officer and Dr. Dushyant Pathak as Vice President of Business Development 2iZumi Bio Appoints Dr. Berta Strulovici as Chief Technology Officer and Dr. Dushyant Pathak as Vice President of Business Development 3
(Date:5/16/2013)... choose to wear the color red when they compete? ... Science , a journal of the Association for Psychological ... their testosterone levels. , The new study, conducted by ... and colleagues, demonstrated that males who chose red as ... levels than other males who chose blue. , "The ...
(Date:5/16/2013)... extinct creature with ,scissor hand-like, claws in fossil records ... movie star. , The 505 million year old ... which is a distant ancestor of lobsters and scorpions, ... starring role as Edward Scissorhands - a movie about ... has scissors for hands. , Kooteninchela deppi ...
(Date:5/16/2013)... trigger hematopoiesis at sites outside the bone marrow ... Ludwig-Maximilians-Universitaet (LMU) in Munich now show that a specific ... of blood cells. , Balanced hematopoiesis is essential for ... hematopoiesis takes place mainly in the liver and the ... marrow, and this tissue normally serves as the sole ...
Breaking Biology News(10 mins):High-testosterone competitors more likely to choose red 2Actor Johnny Depp immortalized in ancient fossil find 2Herpes infections: Natural killer cells activate hematopoiesis 2
... collaboration led to pioneering discoveries about the workings ... circadian rhythms, today were awarded the prestigious Canada ... Michael Rosbash, the Peter and Patricia Gruber ... National Center for Behavioral Genomics, and Professor Emeritus ...
... and Shenzhen, China - To facilitate the genomics ... genomics organization, University of Helsinki and Wuhan University, ... of Understanding (MOU) setting forth a framework for ... of genomics, such as archaeal organisms from hypersaline ...
... ROCKVILLE, Md. -- Each year the American Society of ... women investigators through a competitive process to attend the ... Women,s Young Investigator Travel Award (WYITA) program is to ... years as an independent scientist in academia, industry, or ...
Cached Biology News:Brandeis scientists win prestigious prize for circadian rhythms research 2Brandeis scientists win prestigious prize for circadian rhythms research 3Brandeis scientists win prestigious prize for circadian rhythms research 4American Society of Plant Biologists honors early career women scientists 2